Start planning your trip now & reserve your hotel room! The DC FLI will take place June 8-10.
Held annually in the spring, the AANP DC FLI leadership & advocacy training in Washington, D.C., which culminates in a lobby day on Capitol Hill, will hone your leadership skills, increase your lobbying effectiveness, and give you the opportunity to advocate for the changing face of health care. This is your time to shine! Your participation is essential to federal recognition of the naturopathic profession in EVERY health-care reform initiative.
The DC FLI will train you to represent the profession through interactive workshops, culminating with meetings on Capitol Hill. You'll also benefit from AANP State Alliance sessions, including an exploration of student involvement in state associations. View the agenda here.
WHY SHOULD YOU ATTEND
The DC FLI attracts leaders across the profession. It’s where the most exciting advocacy work of the AANP happens.
The FLI builds momentum
The FLI builds recognition on Capitol Hill of who we are and what we do
The FLI builds confidence in our message and our spirit
By participating in the FLI, you’ll not only boost NDs’ priority national advocacy goals...
You’ll hear from thought leaders both inside and outside of the profession
You’ll make terrific contacts from across the country
You’ll bolster your own state association’s ability to make legislative strides
You’ll also build or polish the skill of confidently presenting yourself
BE AMONG THE ND PROFESSION'S ADVOCACY LEADERS
The DC FLI is an unparalleled opportunity to grow in your chosen profession, to boost your own state association’s advocacy work, and to advance our most important shared national goals. Be part of the enthusiasm and the electricity that comes from the shared commitment to transform America’s healthcare! Join in the 2019 DC FLI.
2019 FEDERAL ASKS 1. Protect Patient Access to Compounded Medications (H.R. 1959)
H.R. 1959 would allow compounding pharmacies to distribute compounded drugs for office-use in all states that allow it, and would clarify that FDA should allow natural and herbal ingredients for compounding in addition to those that are pharmaceutical drugs. Participants will ask members of Congress for co-sponsorship and a hearing for this bill. Glossary of Terms
2. The Mainstreaming Addiction Treatment (MAT) Act (H.R. 2482)
Medical professionals need a special DEA waiver to prescribe buprenorphine to treat substance use disorder, which leads to treatment bottlenecks and a lack of providers. NDs are highly effective at treating pain with non-pharmacological approaches, but in many states also have authority to prescribe opioids and controlled substances in their scope of practice (OR, AZ, VT, CA). However, NDs are not currently eligible under federal law to apply for this DEA waiver. This bill eliminates the redundant, outdated requirement that practitioners apply for a separate waiver to prescribe buprenorphine for substance use disorder treatment. If prescribing DEA Schedules III-V is in the scope of practice of naturopathic doctors as defined by state law, then they would be part of the solution to address America’s opioid crisis. Participants will ask members of Congress to co-sponsor this bill.
3. Congressional Integrative Health & Wellness Caucus
In the midst of the largest American health crisis in recent history, this Caucus will provide legislators and other policy and regulatory officials the opportunity to understand how shifting the focus in healthcare to prevention, health creation and health promotion can result in considerable cost savings while improving health outcomes for all Americans. Participants will ask members of Congress to join the Caucus.